primary sources . please improve this by adding secondary or tertiary sources . june 2011 learn how and when to remove this template message eurogentec type private company industry biotechnology founded 1985 headquarters seraing li ge belgium key people prof. j. martial & a. renard founders j p delwart ceo products proteins plasmids vaccines oligonucleotides qpcr reagents antibodies peptides and fluorophores dyes & quenchers number of employees 390 2011 website www.eurogentec.com eurogentec is an international biotechnology supplier based in belgium that specializes in genomics and proteomics kits and reagents as well as cgmp biologics . the company was founded in 1985 as a spin off from the university of li ge . 1 eurogentec s contract manufacturing organization facilities are licensed by the belgian ministry of health to produce clinical trial and commercial biopharmaceutical material and also licensed by the us fda to manufacture a commercial recombinant protein product for the us market . eurogentec operates two manufacturing facilities in belgium that provide custom biologics and oligonucleotide based components for diagnostic and therapeutic applications . 2 contents 1 history 2 products and services 3 products in development 4 references 5 external links history edit eurogentec biologics division in seraing 1985 the company was founded in li ge by two young researchers from the university of li ge prof. joseph martial and prof. andr renard . prof. joseph martial crossed the atlantic at the end of the 1970s to work at university of california san francisco in an american laboratory and returned a few years later as a trained genetic engineer at a time when these technologies were still largely confined to north america . above all he came back with a certain concept of the economic role potentially assumed by a university researcher in creating his own enterprise . at that time there was no ad hoc structure at the ulg to support the launching of a spin off . prof. j. martial recruited a young researcher prof. a. renard . the laboratory was then welcomed by ulg authorities in their facilities . the company s first goal was to perfect a vaccine for fish breeding through genetic engineering . 1 1987 eurogentec started to distribute olignonucleotides for research laboratories . the company s first years were difficult but in the very early 1990s jean pierre delwart 3 economist from brussels university boarded the ship and put eurogentec in a favorable current . 1 egt north america san diego ca 1996 eurogentec became a contract research organization cro for the biopharmaceutical sector and entered into collaboration with smithkline beecham biologicals rixensart belgium for the production of recombinant proteins for phase i ii and iii clinical trials . in addition to its pharmaceutical manufacturing activities eurogentec became a service company for the biotechnical research industry and university laboratories . 1 1999 eurogentec acquired oswel research product ltd. 4 a biotechnology company based in southampton great britain and specialized in the synthesis of chemically modified and complex oligonucleotides and their analogues dna rna pna . 2002 eurogentec acquired wita proteomics 5 a company specialized in proteomics services based in berlin germany . a few month later eurogentec installed its us office in san diego for the production of oligonucleotides egt na . 6 eurogentec headquarters building in seraing belgium 2004 eurogentec opened its new production laboratories oligonucleotides and peptides synthesis in the liege science park belgium . 7 this intelligent building is also ecological the building is equipped with a home automation system lighting without switch and the heating is produced from a condensation boiler allowing energy savings . 8 from 2000 to 2008 eurogentec intensified its services and signed agreements with several companies like cepheid 9 epoch biosciences 10 exiqon 11 delphi 12 in cell art. 13 2007 in order to fully meet the oligonucleotide in vitro diagnostics stringent manufacturing requirements eurogentec expanded its current gmp facility in li ge . 14 15 2008 eurogentec received iso 13485 certification for the production and sales of in vitro diagnostics ivd oligonucleotides in li ge . two years after egt na 16 also received iso 13485 certification for the oligonucleotide diagnostics manufacturing . anaspec s facility fremont ca 2009 october eurogentec announced the acquisition of anaspec a privately owned proteomics company based in fremont usa . 17 anaspec is a provider of proteomics for life science research ; they specialize in peptides synthesis labelled peptides and antibodies fluorescent dyes and enzyme activity assays . 2010 kaneka acquired a majority stake in eurogentec s.a. 18 kaneka s products include synthetic resins resin products chemicals foodstuffs pharmaceuticals medical devices electrical raw materials and synthetic fibres . 2012 start commercial manufacturing of a biopharmaceutical for usa market . products and services edit eurogentec has developed three interrelated business units life science research products and services in vitro diagnostics manufacturing solutions and gmp biomanufacturing . 2 the life science business unit specializes in genomics e.g. lab scale to large scale oligonucleotides dna polymerases real time qpcr probes and assay dispensing service and proteomics e.g. catalog and custom peptides and antibodies assay kits and proprietary dyes & quenchers . 1 the in vitro diagnostics business unit provides technical and project support for contract manufacturing of good manufacturing practice gmp oligonucleotides and taq dna polymerases for use in molecular diagnostic applications . manufacturing processes take place in clean rooms . 2 the gmp biomanufacturing bu is a full service contract manufacturing organization cmo and offers significant know how in process development technology transfer formulation scale up and manufacturing of gmp proteins protein conjugates plasmids and bacterial vaccines for pre clinical clinical and commercial uses all according to u.s. food and drug administration fda and ema requirements . 2 products in development edit as of september 2014 eurogentec biologics was developing a vaccine against bilharziosis called bilhvax in partnership with inserm and researchers from the pasteur institute ; the vaccine candidate was starting phase iii trials at that time . 19 references edit a b c d e wallonie bruxelles international pdf . pp. 17 18 . retrieved 16 may 2011 . a b c d eurogentec biologics experience true partnership . pharmatching . retrieved 16 may 2011 . paperjam l esprit spin off est ne li ge . 1 february 2008 . pp. 70 71 . 11 may 1999 eurogentec has acquired oswel research products ltd. . 19 december 2002 eurogentec has acquired wita proteomics . 01 october 2002 eurogentec finds a home in philadelphia . bodeux philippe 18 february 2004 . de nouveaux laboratoires de production pour une des premi res spin off de l ulg eurogentec in french . lesoir . retrieved 8 june 2011 . eurogentec trouve sa deuxi me niche in french . la libre . 18 february 2004 . 15 december 2000 cepheid announces distribution agreement with eurogentec for europe . 19 february 2002 eurogentec signed supply agreement with epoch biosciences . 18 march 2003 exiqon and eurogentec announce market licence agreement on the use of locked nucleic acid lna . 03 january 2002 eurogentec signed subcontracting agreement with delphi genetics . 07 april 2008 eurogentec and in cell art collaborate on the commercialisation a novel generation of transfection reagents icafectin 441 and icafectin 442 . 07 april 2008 eurogentec celebrates opening of new gmp manufacturing facilities for ivd oligonucleotides . 28 january 2009 eurogentec recently received iso 13485 2003 certification for the production and sales of in vitro diagnostic ivd oligonucleotides . . 04 september 2010 eurogentec n.a. receives iso 13485 certification . 23 october 2009 eurogentec s.a. finalizes the acquisition of anaspec inc. . 15 june 2010 kaneka and eurogentec s.a. join forces . who . september 2014 . status of vaccine research and development of vaccines for schistosomiasis external links edit official website retrieved from https en.wikipedia.org w index.php title eurogentec & oldid 744170662 categories biotechnology companies of belgiumbiotechnology companiesresearch support companiescontract research organizationspharmaceutical companies established in 1985pharmaceutical companies of belgiumli geserainghidden categories cs1 french language sources fr use dmy dates from january 2013articles lacking reliable references from june 2011all articles lacking reliable referencespages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages fran ais edit links this page was last modified on 13 october 2016 at 15 06 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view